Articles tagged "Heart transplant patients"

2020 American Transplant Congress
Recruitment in the Pediatric Heart Transplant TEAMMATE Trial: Observed vs. Expected
K. P. Daly, L. A. Sleeper, L. J. Addonizio, J. C. Alejos, S. Auerbach, M. J. Bock, A. Butto, W. F. Carlo, C. Castleberry, W. J. Dreyer, B. Feingold, J. M. Lamour, E. L. Albers, S. A. Hollander, G. L. Klein, A. Lal, E. Pahl, D. Peng, A. R. Punnoose, J. W. Rossano, T. D. Ryan, J. Su, D. L. Sutcliffe, S. Zangwill, C. S. Almond
TEAMMATE Trial Investigators, Boston, MA
*Purpose: The TEAMMATE (Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients using the MATE Score) Trial is the first multicenter effort to address key scientific…
2020 American Transplant Congress
Age Mismatch between Donor and Recipient in Heart Transplant and its Effect on Mortality
A. Kumar¹, L. Bonell², M. Prikis¹
¹Internal Medicine, University of Vermont, Burlington, VT, ²Division of General Internal Medicine Research, University of Vermont, Burlington, VT
*Purpose: Increasing donor to recipient age difference has been shown to reduce survival in pediatric heart transplant population. However, the effect of age mismatch in…
2019 American Transplant Congress
Role of Kidney Biopsy in Simultaneous Heart-Kidney Transplantation
P. B. Shah¹, M. A. Josephson¹, K. Henriksen², A. Chang²
¹Nephrology, University of Chicago Medicine, Chicago, IL, ²Pathology, University of Chicago Medicine, Chicago, IL
*Purpose: Simultaneous heart-kidney (SHK) transplantation has superior post-transplant survival compared to heart transplantation alone in end-stage heart failure patients who have dialysis dependent or non-dialysis…
2019 American Transplant Congress
Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States
S. M. Riad¹, A. Tamas¹, S. Jackson², C. Martin¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction regimens for kidney transplant (KT) in heart recipients vary widely among transplant centers. We sought to examine the impact of kidney induction type…
2019 American Transplant Congress
Prognostic Value Of Dobutamine Stress Echocardiography In Heart Transplantation Recipients
A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: Dobutamine stress echocardiography (DSE) carries a class IIa recommendation in the ISHLT guidelines for screening of cardiac allograft vasculopathy (CAV). Positive DSEs have a…
2019 American Transplant Congress
Caregiving before Thoracic Transplantation–A Qualitative Inquiry
C. C. Kennedy¹, J. Ridgeway¹, E. Stevens¹, J. Kirsch², K. Carroll¹, J. Griffin¹, R. Benzo¹
¹Mayo Clinic, Rochester, MN, ²University of Florida-Gainesville, Gainesville, FL
*Purpose: Although post-transplant caregiver (CG) support is a prerequisite for transplant listing, research shows CG outcomes including stress and social functioning may be worse during…
2019 American Transplant Congress
Does the Type of Pre-Heart Transplant Desensitization Therapy Affect 5-Year Post-Transplant Outcomes?
J. Patel, E. Kransdorf, R. Levine, S. Dimbil, L. Czer, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: As many patients with severe heart disease require mechanical circulatory support (MCS), the number of sensitized patients developing circulating antibodies continues to rise. In…
2019 American Transplant Congress
Outcome Of Late Biopsy-negative Rejection After Heart Transplantation
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Biopsy-negative rejection (BNR) is an entity where the endomyocardial biopsy (EMB) shows no findings of rejection, but there is proven cardiac dysfunction i.e. low…
2019 American Transplant Congress
Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients
K. Zaborowski, J. Dedering, R. Felkner
William S. Middleton Memorial Veterans Hospital, Madison, WI
*Purpose: The purpose of this project is to determine the impact pharmacists have on cardiothoracic transplant recipients’ vaccination status at the time of transplant surgery.*Methods:…
2019 American Transplant Congress
Upregulation of Endothelial HLA Class II as a Marker of Antibody Mediated Rejection in Heart Allograft Biopsies
Q. Cai, Y. Butt, A. Hendricks, J. Torrealba
Pathology, UTSW Medical Ctr, Dallas, TX
*Purpose: In 2013, the ISHLT (International Society of Heart and Lung Transplant) introduced the working classification for pathological changes associated with antibody-mediated rejection of the…